Tower Research Capital LLC (Trc) Chembio Diagnostics, Inc. Transaction History

Tower Research Capital LLC (Trc)

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.25 - $0.45 $6 - $10	-24 Reduced 0.24%	9,810 $4,000
Q4 2022 Feb 10, 2023	SELL	$0.2 - $0.33 $151 - $249	-757 Reduced 7.15%	9,834 $2,000
Q3 2022 Nov 10, 2022	SELL	$0.35 - $1.1 $168 - $530	-482 Reduced 4.35%	10,591 $4,000
Q2 2022 Aug 15, 2022	BUY	$0.45 - $0.8 $1,705 - $3,032	3,791 Added 52.06%	11,073 $7,000
Q1 2022 May 12, 2022	BUY	$0.66 - $1.23 $4,806 - $8,956	7,282 New	7,282 $6,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $2.55 $976 - $2,284	-896 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.06 - $5.34 $451 - $1,169	219 Added 32.35%	896 $2,000
Q2 2021 Aug 16, 2021	SELL	$2.88 - $5.64 $9,544 - $18,690	-3,314 Reduced 83.04%	677 $2,000
Q1 2021 May 17, 2021	SELL	$3.4 - $7.97 $5,674 - $13,301	-1,669 Reduced 29.49%	3,991 $14,000
Q4 2020 Feb 16, 2021	SELL	$4.11 - $7.51 $53,783 - $98,275	-13,086 Reduced 69.81%	5,660 $27,000
Q3 2020 Nov 16, 2020	BUY	$3.28 - $5.93 $54,546 - $98,615	16,630 Added 785.92%	18,746 $91,000
Q2 2020 Aug 13, 2020	BUY	$3.18 - $15.54 $6,410 - $31,328	2,016 Added 2016.0%	2,116 $7,000
Q1 2020 May 15, 2020	SELL	$2.36 - $5.6 $3,943 - $9,357	-1,671 Reduced 94.35%	100 $1,000
Q4 2019 Feb 07, 2020	BUY	$3.94 - $5.76 $5,858 - $8,565	1,487 Added 523.59%	1,771 $8,000
Q3 2019 Nov 05, 2019	BUY	$4.84 - $7.25 $1,374 - $2,059	284 New	284 $2,000
Q2 2019 Aug 13, 2019	SELL	$5.56 - $7.85 $6,671 - $9,420	-1,200 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$5.32 - $7.18 $13,411 - $18,100	-2,521 Reduced 67.75%	1,200 $6,000
Q4 2018 Feb 14, 2019	BUY	$4.95 - $10.5 $18,418 - $39,070	3,721 New	3,721 $21,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.